AT
Advanced in Overhydrated Hereditary Stomatocytosis
Check Dr. Andrea S. Teague's experience treating your condition:
About Dr. Andrea S. Teague

Andrea Teague is a Hematologist Oncology specialist and a Hematologist in Santa Fe, New Mexico. Teague has been practicing medicine for over 13 years and is rated as an Advanced expert by MediFind in the treatment of Overhydrated Hereditary Stomatocytosis. She is also highly rated in 27 other conditions, according to our data. Her top areas of expertise are Paget Disease of the Breast, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Lynch Syndrome. She is licensed to treat patients in New Mexico. Teague is currently accepting new patients.

Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 1 clinical trial in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Andrea S. Teague it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
490a W Zia Rd, Santa Fe, NM 87505
Background & Education
Graduate Institution
Albany Medical College Of Union University, 2009
Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in NM
Hospital Affiliations
Miners Colfax Medical Center
CHRISTUS St Vincent Regional Medical Center
CHRISTUS Spohn Hospital Beeville
CHRISTUS Southeast Texas - St Elizabeth
CHRISTUS Santa Rosa Hospital - Medical Center
CHRISTUS Spohn Hospital Corpus Christi - Shoreline
Holy Cross Hospital
Los Alamos Medical Center
CHRISTUS Ochsner St Patrick Hospital
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


1 Clinical Trials

Phase I/II Study Combining Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Distinguished
Advanced